Michael D. West - 11 Mar 2022 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role: Chief Executive Officer, Director
Signature: /s/Michael D. West
Issuer symbol: SER
Transactions as of: 11 Mar 2022
Net transactions value: -$887
Form type: 4
Filing time: 15 Mar 2022, 20:14:36 UTC
Previous filing: 14 Dec 2021
Next filing: 14 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGE	Common Stock, $0.0001 par value	Options Exercise	$0	+3,125	+8.1%	$0.000000	41,696	11 Mar 2022	Direct
transaction	AGE	Common Stock, $0.0001 par value	Tax liability	$887	-1,281	-3.1%	$0.6923	40,415	11 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGE	Restricted Stock Units	Options Exercise	$0	-3,125	-20%	$0.000000	12,500	11 Mar 2022	Common Stock	3,125	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
F2	Restricted Stock Units vested on March 11, 2022.